Expert Video - What are mutation-driven MDS treatments?
MDS expert Rafael Bejar, MD, PhD, explains how mutation-driven treatments for myelodysplastic syndromes (MDS) target changes on specific genes such as IDH1 or IDH2. Other examples include the use of lenalidomide, chromosome deletions in 5q as potential drivers for treatment, and treatments targeted to mutations in the gene FLT3 are present.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
Other Modules:
Animation - Mutation-Driven Therapy in MDS
Slide Show - Mutation-Driven Therapy in MDS
1.
How does my genetic mutation profile impact the treatment of my MDS?
2.
What are mutation-driven MDS treatments?
3.
What are the goals of mutation-driven MDS treatments?
4.
How does my MDS genetic mutation permit personalized treatment decisions?
5.
What questions should I ask my doctor about mutation-driven MDS treatments?
6.
What are the challenges to mutation-driven MDS treatment?
7.
When should genetic testing for MDS be done?
8.
How do MDS genetic mutations influence decisions for stem cell transplant?
9.
Becky's story: How has your gene mutation profile affected your MDS treatment experience?
10.
Donna's story: How has your gene mutation profile affected your MDS treatment experience?
11.
Holly's story: How has your gene mutation profile affected your MDS treatment experience?
12.
Becky's story: What has been the greatest success with your MDS treatment?
13.
Donna's story: What has been the greatest success with your MDS treatment?
14.
Holly's story: What has been the greatest success with your MDS treatment?
15.
Becky's story: What has been the greatest challenge with your MDS treatment?
16.
Donna's story: What has been the greatest challenge with your MDS treatment?
17.
Holly's story: What has been the greatest challenge with your MDS treatment?
